STOCK TITAN

MultiPlan Reports Second Quarter 2021 Results and Updates 2021 Guidance

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

MultiPlan Corporation (NYSE: MPLN) reported strong financial results for Q2 2021, with revenues of $276.3 million, up 33.5% from Q2 2020. The net loss decreased to $46.9 million from $56.2 million the previous year. Adjusted EBITDA rose 37.1% to $205.3 million. The company processed $29.3 billion in claims, identifying $5.0 billion in potential savings. MultiPlan raised its full-year 2021 guidance for revenues and Adjusted EBITDA, expecting lower COVID-19 impacts moving forward. Q3 2021 revenue guidance is projected between $280 million and $295 million.

Positive
  • Q2 2021 revenues increased by 33.5% to $276.3 million.
  • Net loss reduced to $46.9 million from $56.2 million in Q2 2020.
  • Adjusted EBITDA grew by 37.1% year-over-year to $205.3 million.
  • Identified potential medical cost savings of $5.0 billion from $29.3 billion in claims processed.
  • Increased full-year 2021 guidance for revenues, Adjusted EBITDA, and cash flow from operations.
Negative
  • Despite revenue growth, the company still reported a significant net loss of $46.9 million.
  • The ongoing COVID-19 pandemic continues to create an estimated revenue impact of $9-11 million per quarter.

MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today reported financial results for the second quarter ended June 30, 2021.

“MultiPlan’s momentum continues, with a second quarter that marks our fourth consecutive report of strong quarterly performance during our first year as public company,” said Mark Tabak, CEO of MultiPlan. “Despite the ongoing effects and uncertainty of the COVID-19 pandemic on our business, we continue to produce results through an unyielding commitment to operational excellence and delivering value to our customers. Importantly, in the second quarter, we had growth across all of our services lines and all of our major customer groups. In consideration of our strong second quarter results, indications that the headwinds from COVID-19 have weakened, and an improved outlook for the second half of the year, we are raising our financial guidance for full-year 2021.”

The Company remains focused on its mission of delivering fairness, efficiency and affordability to the U.S. healthcare system and on driving sustained long-term growth by enhancing its product offerings to payors, extending into new payor customer segments, and expanding its platform to serve MultiPlan’s 1.2 million providers, its more than 700 payor customers, and 60 plus million consumers.

Business and Financial Highlights

  • Revenues of $276.3 million for Q2 2021, an increase of 33.5% over Q2 2020 revenues of $206.9 million.
  • Net loss of $46.9 million for Q2 2021 compared to net loss of $56.2 million for Q2 2020.
  • Adjusted EBITDA of $205.3 million for Q2 2021, an increase of 37.1% over Q2 2020 Adjusted EBITDA of $149.8 million
  • The Company processed approximately $29.3 billion in claims during the second quarter of 2021, identifying potential medical cost savings of approximately $5.0 billion.

2021 Financial Guidance

The Company is increasing its Full Year 2021 guidance for revenues, Adjusted EBITDA and cash flow from operations, reflecting the combination of: expectation that the impact of the COVID-19 pandemic on revenue and Adjusted EBITDA in the second half of 2021 will be lower than the Company’s prior estimates; continued organic growth in revenues driven by a strong pipeline of service implementations with customers, and better-than-anticipated Q2 2021 results. A comparison of the Company’s prior and revised Full Year 2021 guidance is presented in the table below.

Financial Metric

 

Prior FY 2021 Guidance

 

Updated FY 2021 Guidance

Revenues

 

$1,040 million to $1,100 million

 

$1,090 million to $1,130 million

Adj. EBITDA

 

$750 million to $790 million

 

$810 million to $835 million

Cash flow from operations

 

$380 million to $420 million

 

$410 million to $440 million

Capital expenditures

 

$75 million to $80 million

 

$75 million to $80 million

Interest expense

 

$250 million to $260 million

 

$250 million to $260 million

Depreciation

 

$60 million to $65 million

 

$65 million to $70 million

Amortization of intangible assets

 

$340 million to $345 million

 

$335 million to $345 million

Effective tax rate

 

25% to 28%

 

25% to 28%

The Company anticipates Q3 2021 revenues between $280 million and $295 million with Adjusted EBITDA between $205 million and $215 million. The above quarterly and annual guidance reflects an estimated COVID-related revenue impact of $9-11 million per quarter and an estimated COVID-related Adjusted EBITDA impact of $7-9 million per quarter in the second half of 2021, as compared with a revenue impact of $18-22 million in Q1 2021 and $9-11 million in Q2 2021 and an Adjusted EBITDA impact of $16-$18 million in Q1 2021 and $7-9 million in Q2 2021.

Excluding the estimated potential impact of the COVID-19 pandemic and contributions from acquired businesses, the Company’s FY 2021 guidance implies a range of revenues of $1,085 million to $1,135 million, compared to a range of revenues of $1,085 million to $1,125 million for the FY 2021 estimated forecast provided in the 2020 Proxy Statement. Excluding the estimated potential impact of the COVID-19 pandemic, contributions from acquired businesses, and public company costs, the Company’s guidance implies a range of Adjusted EBITDA of $848 million to $883 million, compared to a range of Adjusted EBITDA of $845 million to $875 million for the FY 2021 forecast provided in the 2020 Proxy Statement. The FY 2021 estimated forecast provided in the 2020 Proxy Statement was based on numerous variables and assumptions known to the Company at the time of preparation, and these assumptions and variables did not include any estimated potential impact from the COVID-19 pandemic, acquisitions, or public company costs.

Conference Call Information

The Company will host a conference call today, Thursday, August 5, 2021 at 8:00 a.m. U.S. Eastern Time (ET) to discuss its financial results. Interested investors and other parties can register for the conference call using the link below:

http://www.directeventreg.com/registration/event/8938558

A live webcast of the conference call can be accessed through the Investor Relations section of the Company’s website at investors.multiplan.com/events-and-presentations. Participants should join the webcast ten minutes prior to the start of the conference call. A supplemental slide deck will also be available on this section of the MultiPlan website.

For those unable to listen to the live conference call, a replay will be available approximately two hours after the call through the archived webcast on the Investor Relations section of the Company’s website.

About MultiPlan

MultiPlan is committed to helping healthcare payors manage the cost of care, improve their competitiveness and inspire positive change. Leveraging sophisticated technology, data analytics and a team rich with industry experience, MultiPlan interprets clients' needs and customizes innovative solutions that combine its payment and revenue integrity, network-based and analytics-based services. MultiPlan is a trusted partner to over 700 healthcare payors in the commercial health, government and property and casualty markets. For more information, visit multiplan.com.

Forward Looking Statements

This press release includes statements that express our and our subsidiaries’ opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements”. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “seeks,” “projects,” “forecasts,” “intends,” “plans,” “may,” “will” or “should” or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this press release, including the discussion of 2021 guidance, and these forward-looking statements reflect management’s expectations regarding our future growth, results of operations, operational and financial performance and business prospects and opportunities. Such forward-looking statements are based on available current market material and management’s expectations, beliefs and forecasts concerning future events impacting the business. Although we believe that these forward-looking statements are based on reasonable assumptions at the time they are made, you should be aware that many factors could affect our actual financial results, including: the impact from the COVID-19 pandemic and its related effects on our projected results of operations, financial performance or other financial metrics; loss of our customers, particularly our largest customers; decreases in our existing market share or the size of our Preferred Provider Organization networks; effects of competition; effects of pricing pressure; the inability of our customers to pay for our services; decreases in discounts from providers; the loss of our existing relationships with providers; the loss of key members of our management team; pressure to limit access to preferred provider networks; the ability to achieve the goals of our strategic plans and recognize the anticipated strategic, operational, growth and efficiency benefits when expected; our ability to identify, complete and successfully integrate acquisitions; changes in our industry; interruptions or security breaches of our information technology systems; our ability to protect proprietary applications; our inability to expand our network infrastructure; our ability to remediate any material weakness or maintain effective internal controls over financial reporting; changes in our regulatory environment, including healthcare law and regulations; the expansion of privacy and security laws; heightened enforcement activity by government agencies; our ability to pay interest and principal on our notes and other indebtedness; the possibility that we may be adversely affected by other political, economic, business, and/or competitive factors; other factors disclosed in our Securities and Exchange Commission (“SEC”) filings; and other factors beyond our control.

The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and potential effects on our business. There can be no assurance that future developments affecting our business will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2021, including those under “Risk Factors” therein, and other documents filed or to be filed with the SEC by us. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Forward-looking statements speak only as of the date made. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Non-GAAP Financial Measures

In addition to the financial measures prepared in accordance with generally accepted accounting principles in the United States (“GAAP”), this press release contains certain non-GAAP financial measures, including EBITDA, Adjusted EBITDA, Unlevered Free Cash Flow and Adjusted cash conversion ratio. A non-GAAP financial measure is generally defined as a numerical measure of a company’s financial or operating performance that excludes or includes amounts so as to be different than the most directly comparable measure calculated and presented in accordance with GAAP.

EBITDA, Adjusted EBITDA, Unlevered Free Cash Flow and Adjusted cash conversion ratio are supplemental measures of MultiPlan’s performance that are not required by or presented in accordance with GAAP. These measures are not measurements of our financial or operating performance under GAAP, have limitations as analytical tools and should not be considered in isolation or as an alternative to net income (loss), cash flows or any other measures of performance prepared in accordance with GAAP.

EBITDA represents net income (loss) before interest expense, interest income, income tax provision (benefit), depreciation, amortization of intangible assets, and non-income taxes. Adjusted EBITDA is EBITDA as further adjusted by certain items as described in the table below.

In addition, in evaluating EBITDA and Adjusted EBITDA you should be aware that in the future, we may incur expenses similar to the adjustments in the presentation of EBITDA and Adjusted EBITDA. The presentation of EBITDA and Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. The calculations of EBITDA and Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. Based on our industry and debt financing experience, we believe that EBITDA and Adjusted EBITDA are customarily used by investors, analysts and other interested parties to provide useful information regarding a company’s ability to service and/or incur indebtedness.

We also believe that Adjusted EBITDA is useful to investors and analysts in assessing our operating performance during the periods these charges were incurred on a consistent basis with the periods during which these charges were not incurred. Both EBITDA and Adjusted EBITDA have limitations as analytical tools, and you should not consider either in isolation, or as a substitute for analysis of our results as reported under GAAP. Some of the limitations are:

  • EBITDA and Adjusted EBITDA do not reflect changes in, or cash requirements for, our working capital needs;
  • EBITDA and Adjusted EBITDA do not reflect interest expense, or the cash requirements necessary to service interest or principal payments on our debt;
  • EBITDA and Adjusted EBITDA do not reflect our tax expense or the cash requirements to pay our taxes; and
  • Although depreciation and amortization are non-cash charges, the tangible assets being depreciated will often have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements.

​MultiPlan’s presentation of Adjusted EBITDA should not be construed as an inference that our future results and financial position will be unaffected by unusual items.

Unlevered Free Cash Flow is defined as net cash provided by (used in) operating activities less capital expenditures, plus cash interest paid, all as disclosed in the Statements of Cash Flows. Unlevered Free Cash Flow is a measure of our operational performance used by management to evaluate our business prior to the impact of our capital structure and after purchases of property and equipment. Unlevered Free Cash Flow should be considered in addition to, rather than as a substitute for, consolidated net income as a measure of our performance and net cash provided by operating activities as a measure of our liquidity. Additionally, MultiPlan's definition of Unlevered Free Cash Flow is limited, in that it does not represent residual cash flows available for discretionary expenditures, due to the fact that the measure does not deduct the payments required for debt service and other contractual obligations or payments made for business acquisitions.

Adjusted cash conversion ratio is defined as Unlevered Free Cash Flow divided by Adjusted EBITDA. MultiPlan believes that the presentation of the Adjusted cash conversion ratio provides useful information to investors because it is a financial performance measure that shows how much of its Adjusted EBITDA MultiPlan converts into Unlevered Free Cash Flow.

We have not reconciled the forward-looking Adjusted EBITDA guidance included above to the most directly comparable GAAP measure because this cannot be done without unreasonable effort due to the variability and low visibility with respect to certain costs, the most significant of which are incentive compensation (including stock-based compensation), transaction-related expenses (including expenses relating to the business combination), certain fair value measurements and costs related to the uncertainties caused by the global COVID-19 pandemic, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.

MULTIPLAN CORPORATION

 

Unaudited Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

 

 

June 30,
2021

 

December 31,
2020

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

147,971

 

 

$

126,755

 

Trade accounts receivable, net

61,127

 

 

63,198

 

Prepaid expenses

16,657

 

 

17,708

 

Prepaid taxes

54,148

 

 

 

Other current assets, net

1,377

 

 

1,193

 

Total current assets

281,280

 

 

208,854

 

Property and equipment, net

199,616

 

 

187,631

 

Operating lease right-of-use assets

28,839

 

 

31,339

 

Goodwill

4,365,785

 

 

4,257,336

 

Other intangibles, net

3,455,372

 

 

3,584,187

 

Other assets

7,934

 

 

14,231

 

Total assets

$

8,338,826

 

 

$

8,283,578

 

Liabilities and Shareholders’ Equity

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

10,586

 

 

$

15,261

 

Accrued interest

29,596

 

 

31,528

 

Accrued taxes

 

 

10,176

 

Operating lease obligation, short-term

6,833

 

 

6,439

 

Accrued compensation

35,244

 

 

21,843

 

Other accrued expenses

29,506

 

 

27,251

 

Total current liabilities

111,765

 

 

112,498

 

Long-term debt

4,882,240

 

 

4,578,488

 

Operating lease obligation, long-term

24,717

 

 

27,499

 

Private Placement Warrants and unvested founder shares

147,780

 

 

106,595

 

Deferred income taxes

837,073

 

 

900,633

 

Other liabilities

187

 

 

 

Total liabilities

6,003,762

 

 

5,725,713

 

Commitments and contingencies (Note 6)

 

 

 

Shareholders’ equity:

 

 

 

Shareholder interests

 

 

 

Preferred stock, $0.0001 par value — 10,000,000 shares authorized; no shares issued

 

Common stock, $0.0001 par value — 1,500,000,000 shares authorized; 665,033,300 and 664,183,318 issued; 655,612,160 and 655,075,355 shares outstanding

66

 

 

66

 

Additional paid-in capital

2,304,954

 

 

2,530,410

 

Retained earnings

121,977

 

 

116,999

 

Treasury stock — 9,421,140 and 9,107,963 shares

(91,933

)

 

(89,610

)

Total shareholders’ equity

2,335,064

 

 

2,557,865

 

Total liabilities and shareholders’ equity

$

8,338,826

 

 

$

8,283,578

 

MULTIPLAN CORPORATION

 

Unaudited Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss)

(in thousands, except share and per share data)

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

2021

 

2020

 

2021

 

2020

Revenues

$

276,272

 

 

$

206,880

 

 

$

531,136

 

 

$

458,902

 

Costs of services (exclusive of depreciation and amortization of intangible assets shown below)

44,368

 

 

51,894

 

 

84,098

 

 

96,579

 

General and administrative expenses

39,927

 

 

36,066

 

 

71,923

 

 

57,767

 

Depreciation

17,008

 

 

15,135

 

 

33,173

 

 

29,641

 

Amortization of intangible assets

85,167

 

 

83,514

 

 

169,875

 

 

167,027

 

Total expenses

186,470

 

 

186,609

 

 

359,069

 

 

351,014

 

Operating income

89,802

 

 

20,271

 

 

172,067

 

 

107,888

 

Interest expense

64,004

 

 

86,050

 

 

127,721

 

 

177,015

 

Interest income

(7

)

 

(77

)

 

(11

)

 

(148

)

Gain on investments

(25

)

 

 

 

(25

)

 

 

Change in fair value of Private Placement Warrants and unvested founder shares

81,560

 

 

 

 

41,185

 

 

 

Net (loss) income before income taxes

(55,730

)

 

(65,702

)

 

3,197

 

 

(68,979

)

(Benefit) provision for income taxes

(8,798

)

 

(9,456

)

 

4,252

 

 

(10,139

)

Net loss

(46,932

)

 

(56,246

)

 

$

(1,055

)

 

$

(58,840

)

 

 

 

 

 

 

 

 

Weighted average shares outstanding – Basic1

655,609,718

 

 

415,700,000

 

 

655,361,621

 

 

415,700,000

 

Weighted average shares outstanding – Diluted1

655,609,718

 

 

415,700,000

 

 

655,361,621

 

 

415,700,000

 

 

 

 

 

 

 

 

 

Net loss per share – Basic

$

(0.07

)

 

$

(0.14

)

 

$

(0.00

)

 

$

(0.14

)

Net loss per share – Diluted

$

(0.07

)

 

$

(0.14

)

 

$

(0.00

)

 

$

(0.14

)

 

 

 

 

 

 

 

 

Comprehensive loss

(46,932

)

 

(56,246

)

 

$

(1,055

)

 

$

(58,840

)

1 In accordance with the accounting guidance, the number of shares outstanding prior to the business combination of Polaris Parent Corp. and Churchill Capital Corp III (the “Transactions”) was 415,700,000, which represents the 10 historical shares of Polaris Parent Corp. multiplied by the exchange ratio established in the Transactions (41,570,000:1). At the date of the Transactions, the number of shares outstanding increased to 655,057,192. The increase represents the shares issued by Churchill Capital Corp III prior to the Transactions and the shares issued to PIPE investors at the time of the Transactions, net of shares redeemed and held in treasury upon closing.

MULTIPLAN CORPORATION

 

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)

 

 

Six Months Ended June 30,

 

2021

 

2020

Operating activities:

 

 

 

Net loss

$

(1,055

)

 

$

(58,840

)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

Depreciation

33,173

 

 

29,641

 

Amortization of intangible assets

169,875

 

 

167,027

 

Amortization of the right-of-use asset

3,525

 

 

4,578

 

Stock-based compensation

8,442

 

 

37,272

 

Deferred income taxes

303

 

 

(7,890

)

Non-cash interest costs

5,805

 

 

9,098

 

Loss on disposal of property and equipment

685

 

 

101

 

Change in fair value of Private Placement Warrants and unvested founder shares

41,185

 

 

 

Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions:

 

 

 

Accounts receivable, net

4,952

 

 

23,067

 

Prepaid expenses and other assets

2,468

 

 

(941

)

Prepaid taxes

(54,148

)

 

(5,556

)

Operating lease obligation

(3,417

)

 

(4,790

)

Accounts payable and accrued expenses and other

(7,404

)

 

(900

)

Net cash provided by operating activities

204,389

 

 

191,867

 

Investing activities:

 

 

 

Purchases of property and equipment

(36,787

)

 

(34,866

)

Proceeds from sale of investment

5,641

 

 

 

HST Acquisition, net of cash acquired

(28

)

 

 

DHP Acquisition, net of cash acquired

(149,676

)

 

 

Net cash used in investing activities

(180,850

)

 

(34,866

)

Financing activities:

 

 

 

Borrowings on revolving credit facility

 

 

98,000

 

Repayment of revolving credit facility

 

 

(98,000

)

Purchase of treasury stock

(2,323

)

 

 

Borrowings (payments) on finance leases, net

 

 

34

 

Net cash (used in) provided by financing activities

(2,323

)

 

34

 

Net increase in cash and cash equivalents

21,216

 

 

157,035

 

Cash and cash equivalents at beginning of period

126,755

 

 

21,825

 

Cash and cash equivalents at end of period

$

147,971

 

 

$

178,860

 

Noncash investing and financing activities:

 

 

 

Purchases of property and equipment not yet paid

$

3,913

 

 

$

2,664

 

Operating lease right-of-use assets obtained in exchange for operating lease liabilities

$

1,025

 

 

$

467

 

Supplemental disclosure of cash flow information:

 

 

 

Cash paid during the period for:

 

 

 

Interest

$

(123,115

)

 

$

(167,836

)

Income taxes, net of refunds

$

(68,766

)

 

$

(3,407

)

MULTIPLAN CORPORATION

 

Calculation of EBITDA and Adjusted EBITDA

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

(in thousands)

2021

 

2020

 

2021

 

2020

 

 

 

 

 

 

 

 

Net loss

$

(46,932

)

 

$

(56,246

)

 

$

(1,055

)

 

$

(58,840

)

Adjustments:

 

 

 

 

 

 

 

Interest expense

64,004

 

 

86,050

 

 

127,721

 

 

177,015

 

Interest income

(7

)

 

(77

)

 

(11

)

 

(148

)

Income tax provision (benefit)

(8,798

)

 

(9,456

)

 

4,252

 

 

(10,139

)

Depreciation

17,008

 

 

15,135

 

 

33,173

 

 

29,641

 

Amortization of intangible assets

85,167

 

 

83,514

 

 

169,875

 

 

167,027

 

Non-income taxes

489

 

 

481

 

 

1,002

 

 

920

 

EBITDA

$

110,931

 

 

$

119,401

 

 

$

334,957

 

 

$

305,476

 

Adjustments:

 

 

 

 

 

 

 

Other expenses

4,182

 

 

149

 

 

5,399

 

 

297

 

Change in fair value of Private Placement Warrants and unvested founder shares

81,560

 

 

 

 

41,185

 

 

 

Transaction-related expenses

1,206

 

 

2,338

 

 

6,431

 

 

2,698

 

Gain on investments

(25

)

 

 

 

(25

)

 

 

Stock-based compensation

7,474

 

 

27,911

 

 

8,442

 

 

37,272

 

Adjusted EBITDA

$

205,328

 

 

$

149,799

 

 

$

396,389

 

 

$

345,743

 

Calculation of Unlevered Free Cash Flow and Adjusted Cash Conversion Ratio

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

(in thousands)

2021

 

2020

 

2021

 

2020

 

 

 

 

 

 

 

 

Net cash provided by operating activities

$

33,482

 

 

$

44,474

 

 

$

204,389

 

 

$

191,867

 

Purchases of property and equipment

(18,674

)

 

(17,530

)

 

(36,787

)

 

(34,866

)

Interest paid

100,836

 

 

135,558

 

 

123,115

 

 

167,836

 

Unlevered Free Cash Flow

$

115,644

 

 

$

162,502

 

 

$

290,717

 

 

$

324,837

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

205,328

 

 

$

149,799

 

 

$

396,389

 

 

$

345,743

 

Adjusted Cash Conversion Ratio

56

%

 

108

%

 

73

%

 

94

%

 

 

 

 

 

 

 

 

Net cash used in investing activities

(18,452

)

 

(17,530

)

 

(180,850

)

 

(34,866

)

Net cash (used in) provided by financing activities

(2,091

)

 

(97,959

)

 

(2,323

)

 

34

 

 

FAQ

What were MultiPlan's Q2 2021 revenues?

MultiPlan reported Q2 2021 revenues of $276.3 million, a 33.5% increase compared to $206.9 million in Q2 2020.

How much did MultiPlan raise its financial guidance for 2021?

MultiPlan raised its 2021 revenue guidance to between $1,090 million and $1,130 million, up from the prior range of $1,040 million to $1,100 million.

What was the net loss for MultiPlan in Q2 2021?

The net loss for Q2 2021 was $46.9 million, a reduction from $56.2 million in the same quarter of the previous year.

What is the projected revenue for Q3 2021 for MultiPlan?

MultiPlan projects Q3 2021 revenues between $280 million and $295 million.

How did MultiPlan's Adjusted EBITDA perform in Q2 2021?

MultiPlan's Adjusted EBITDA for Q2 2021 was $205.3 million, representing a 37.1% increase from $149.8 million in Q2 2020.

MultiPlan Corporation

NYSE:MPLN

MPLN Rankings

MPLN Latest News

MPLN Stock Data

103.01M
8.33M
7.95%
81.52%
1.64%
Health Information Services
Services-business Services, Nec
Link
United States of America
NEW YORK